Top compounds associated with response to SRI


Feature Type Standardized
Nominal ANOVA
mRNA Sunitinib GDSC1000 pan-cancer AAC -0.091 0.08
mRNA SR-II-138A CTRPv2 pan-cancer AAC -0.056 0.08
mRNA paclitaxel FIMM pan-cancer AAC 0.23 0.08
mRNA SB590885 GDSC1000 pan-cancer AAC 0.057 0.08
mRNA Oxaliplatin CTRPv2 pan-cancer AAC -0.058 0.08
mRNA SGX-523 CTRPv2 pan-cancer AAC 0.065 0.09
mRNA QL-XII-61 GDSC1000 pan-cancer AAC -0.082 0.09
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC -0.051 0.09
mRNA QW-BI-011 CTRPv2 pan-cancer AAC -0.12 0.09
mRNA PF-3758309 CTRPv2 pan-cancer AAC -0.076 0.09
Download CSV